Abbott Laboratories ROE 2010-2025 | ABT

Current and historical return on equity (ROE) values for Abbott Laboratories (ABT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Abbott Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-06-30 $13.98B 40.82%
2025-03-31 $13.50B $49.06B 30.59%
2024-12-31 $13.40B $47.90B 32.19%
2024-09-30 $5.77B $40.03B 14.65%
2024-06-30 $5.56B $39.56B 14.33%
2024-03-31 $5.63B $39.04B 14.72%
2023-12-31 $5.72B $38.83B 15.14%
2023-09-30 $5.16B $37.69B 13.84%
2023-06-30 $5.16B $37.40B 14.00%
2023-03-31 $5.80B $37.23B 15.82%
2022-12-31 $6.93B $36.91B 19.11%
2022-09-30 $7.89B $35.88B 21.88%
2022-06-30 $8.55B $36.72B 23.93%
2022-03-31 $7.73B $35.63B 22.02%
2021-12-31 $7.07B $36.02B 20.42%
2021-09-30 $7.24B $34.64B 21.39%
2021-06-30 $6.38B $34.03B 19.26%
2021-03-31 $5.72B $33.79B 17.72%
2020-12-31 $4.50B $33.00B 14.29%
2020-09-30 $3.38B $31.60B 10.90%
2020-06-30 $3.11B $30.80B 9.99%
2020-03-31 $3.58B $30.43B 11.39%
2019-12-31 $3.69B $31.30B 11.67%
2019-09-30 $3.29B $32.02B 10.47%
2019-06-30 $2.90B $31.89B 9.29%
2019-03-31 $2.62B $31.13B 8.49%
2018-12-31 $2.37B $30.72B 7.64%
2018-09-30 $0.89B $30.90B 2.85%
2018-06-30 $0.93B $30.77B 2.95%
2018-03-31 $0.48B $31.60B 1.50%
2017-12-31 $0.48B $31.10B 1.51%
2017-09-30 $2.10B $32.22B 7.23%
2017-06-30 $1.17B $31.79B 4.46%
2017-03-31 $1.50B $31.55B 6.40%
2016-12-31 $1.40B $20.72B 6.73%
2016-09-30 $1.37B $20.90B 6.53%
2016-06-30 $2.28B $20.80B 10.82%
2016-03-31 $2.45B $20.84B 11.31%
2015-12-31 $4.42B $21.33B 20.18%
2015-09-30 $4.56B $21.22B 20.74%
2015-06-30 $4.52B $23.13B 20.14%
2015-03-31 $4.20B $21.99B 18.60%
2014-12-31 $2.28B $21.64B 9.95%
2014-09-30 $1.97B $22.99B 8.25%
2014-06-30 $2.40B $23.70B 9.96%
2014-03-31 $2.41B $23.49B 10.14%
2013-12-31 $2.58B $25.27B 10.94%
2013-09-30 $3.04B $23.79B 12.70%
2013-06-30 $4.02B $22.43B 16.22%
2013-03-31 $5.27B $22.68B 20.82%
2012-12-31 $5.96B $26.81B 22.93%
2012-09-30 $6.53B $27.10B 25.67%
2012-06-30 $4.89B $24.57B 19.69%
2012-03-31 $5.11B $25.54B 20.18%
2011-12-31 $4.73B $24.53B 18.84%
2011-09-30 $4.55B $24.69B 18.45%
2011-06-30 $5.14B $26.47B 21.54%
2011-03-31 $4.49B $24.72B 20.18%
2010-12-31 $4.63B $22.77B 21.71%
2010-09-30 $4.73B $21.48B 22.06%
2010-06-30 $5.31B $20.00B 24.84%
2010-03-31 $5.31B $21.01B 24.84%
2009-12-31 $5.75B $23.19B 27.87%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $209.668B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Medtronic (MDT) Ireland $114.826B 16.28
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Baxter (BAX) United States $14.312B 10.69
Smith & Nephew SNATS (SNN) United Kingdom $13.087B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Phibro Animal Health (PAHC) United States $1.205B 15.40
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00